Andrea Popelova

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models.

Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models.

Journal: Frontiers in pharmacology

Published: September 27, 2021

Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study.

Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study.

Journal: Current Alzheimer research

Published: June 14, 2021

Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22.

Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22.

Journal: Journal of neuroinflammation

Published: March 12, 2021

Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells.

Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells.

Journal: International journal of molecular sciences

Published: July 10, 2020

Prolactin-Releasing Peptide: Physiological and Pharmacological Properties.

Prolactin-Releasing Peptide: Physiological and Pharmacological Properties.

Journal: International journal of molecular sciences

Published: October 02, 2019

The use of 1,5-diaminonaphthalene for matrix-assisted laser desorption/ionization mass spectrometry imaging of brain in neurodegenerative disorders.

The use of 1,5-diaminonaphthalene for matrix-assisted laser desorption/ionization mass spectrometry imaging of brain in neurodegenerative disorders.

Journal: Talanta

Published: November 30, 2018

The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology.

The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology.

Journal: The Journal of endocrinology

Published: November 12, 2018

Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.

Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.

Journal: Neuropharmacology

Published: July 25, 2018

Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.

Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.

Journal: Journal of Alzheimer's disease : JAD

Published: April 05, 2018

Potential neuroprotective and anti-apoptotic properties of a long-lasting stable analog of ghrelin: an in vitro study using SH-SY5Y cells.

Potential neuroprotective and anti-apoptotic properties of a long-lasting stable analog of ghrelin: an in vitro study using SH-SY5Y cells.

Journal: Physiological research

Published: January 06, 2018

Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity.

Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity.

Journal: PloS one

Published: December 28, 2016

Prolactin-releasing peptide: a new tool for obesity treatment.

Prolactin-releasing peptide: a new tool for obesity treatment.

Journal: The Journal of endocrinology

Published: May 11, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026